Палиперидон в лечении острой шизофрении у подростков

Сторожакова Янина Абрамовна · Социальная и клиническая психиатрия · 2014

The article is an extended summary of the paper presenting the results of a randomized double-blind study of Paliperidone extended-release (ER) in the treatment of acute schizophrenia in adolescents. The effi cacy and good tolerability of Paliperidone ER (1.5-12 mg once daily) is proven. Weightbased dosing of Paliperidone ER in adolescents with schizophrenia does not appear to be necessary.

Cited by 0 works.

Authors